======= CDKN2C ======= == Gene Information == * **Official Symbol**: CDKN2C * **Official Name**: cyclin dependent kinase inhibitor 2C * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1031|1031]] * **UniProt**: [[https://www.uniprot.org/uniprot/P42773|P42773]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CDKN2C&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CDKN2C|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603369|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Interacts strongly with CDK6, weakly with CDK4. Inhibits cell growth and proliferation with a correlated dependence on endogenous retinoblastoma protein RB. |Ank 2| |Ank| |cyclin-dependent protein serine/threonine kinase inhibitor activity| |negative regulation of cyclin-dependent protein serine/threonine kinase activity| |negative regulation of cyclin-dependent protein kinase activity| |oligodendrocyte differentiation| |regulation of cyclin-dependent protein serine/threonine kinase activity| |regulation of cyclin-dependent protein kinase activity| |negative regulation of G1/S transition of mitotic cell cycle| |negative regulation of cell cycle G1/S phase transition| |G1/S transition of mitotic cell cycle| |cell cycle G1/S phase transition| |negative regulation of protein serine/threonine kinase activity| |cell cycle arrest| |regulation of G1/S transition of mitotic cell cycle| |regulation of cell cycle G1/S phase transition| |glial cell differentiation| |negative regulation of cell growth| |negative regulation of mitotic cell cycle phase transition| |gliogenesis| |negative regulation of protein kinase activity| |negative regulation of cell cycle phase transition| |negative regulation of growth| |negative regulation of kinase activity| |mitotic cell cycle phase transition| |negative regulation of transferase activity| |cell cycle phase transition| |negative regulation of mitotic cell cycle| |negative regulation of cell cycle process| |negative regulation of protein phosphorylation| |regulation of mitotic cell cycle phase transition| |regulation of cell growth| |negative regulation of phosphorylation| |regulation of cell cycle phase transition| |protein kinase binding| |regulation of protein serine/threonine kinase activity| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of cell cycle| |negative regulation of protein modification process| |mitotic cell cycle process| |regulation of mitotic cell cycle| |regulation of growth| |negative regulation of cell population proliferation| |mitotic cell cycle| |regulation of cell cycle process| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |regulation of transferase activity| |central nervous system development| |cell cycle process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of cell cycle| |cell cycle| |regulation of protein phosphorylation| |regulation of phosphorylation| |regulation of cell population proliferation| |neurogenesis| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|-1.85| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13951 * **Expression level (log2 read counts)**: 5.77 {{:chemogenomics:nalm6 dist.png?nolink |}}